Inhibrx Biosciences, Inc. - INBX

Latest data: 5/30/2025 10:06:21 PM
EDGAR CIK 0002007919

Buy Breakdown

Total $2,415,312

Sell Breakdown

Total $0

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
09/16/2024
09/16/2024
Chief Executive Officer
CEO Director
Buy
13,037 @ $17.13
$223,323.81
705,548 (1.88%) Indirect - By the Lappe Family Trust
09/12/2024
09/16/2024
Chief Executive Officer
CEO Director
Buy
26,963 @ $15.05
$405,793.15
692,511 (4.05%) Indirect - By the Lappe Family Trust
09/10/2024
09/10/2024
Chief Executive Officer
CEO Director
Buy
8,500 @ $15.19
$129,115.00
665,548 (1.29%) Indirect - By the Lappe Family Trust
09/09/2024
09/10/2024
Chief Executive Officer
CEO Director
Buy
9,500 @ $15.21
$144,495.00
657,048 (1.47%) Indirect - By the Lappe Family Trust
09/06/2024
09/10/2024
Chief Executive Officer
CEO Director
Buy
26,000 @ $15.29
$397,540.00
647,548 (4.18%) Indirect - By the Lappe Family Trust
09/03/2024
09/03/2024
Chief Executive Officer
CEO Director
Buy
20,000 @ $15.81
$316,262.80
165,000 (13.79%) Indirect - By Lappe Descendants' Trust
08/30/2024
09/03/2024
Chief Executive Officer
CEO Director
Buy
10,000 @ $14.02
$140,200.00
145,000 (7.41%) Indirect - By Lappe Descendants' Trust
08/29/2024
09/03/2024
Chief Executive Officer
CEO Director
Buy
10,000 @ $14.03
$140,300.00
135,000 (8.00%) Indirect - By Lappe Descendants' Trust
08/21/2024
08/22/2024
Chief Executive Officer
CEO Director
Buy
12,945 @ $12.93
$167,378.85
54,865 (30.88%) Indirect - The Mark Paul Lappe Roth IRA
08/20/2024
08/22/2024
Chief Executive Officer
CEO Director
Buy
27,055 @ $12.97
$350,903.35
41,920 (182.00%) Indirect - The Mark Paul Lappe Roth IRA